Sarcoma patients harboring the CIC::FOXO4 fusion also had a high rate of pulmonary metastasis (75%; total n = 4), while patients with the CIC::NUTM1 tumors had the lowest overall rate of metastasis (25%; total n = 12) with distant sites including the lungs, thyroid, bone, and brain (Solomon et al., 2014; Sugita et al., 2014; Mangray et al., 2018; Schaefer et al., 2018; Le Loarer et al., 2019; Biederman et al., 2022; Connolly et al., 2022; Yang et al., 2022; Babkoff et al., 2023; Ma et al., 2023; Sievers et al., 2023). The gene discussed is NUTM1; the disease is sarcoma.